Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1100_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
02.09.2026
Размер:
21 Мб
Скачать
174 J. Shindoh and J.-N. Vauthey
S2/3
S1
Right + Seg 4 PVE
Pre-PVE FLR (Seg1-3)
10% vs. Total Liver Volume
Fig. 17.4 Regeneration of the future liver remnant ( FLR) after right + segment IV portal vein embolization ( PVE). Seg segment, S segment
Portal Vein Embolization
IV portal vein [24, 25] have been recommended.
Post-PVE FLR (Seg 1-3)
33% vs. Total Liver Volume
S2/3
S1
Our previous work comparing right PVE with Portal vein embolization (PVE) is a safe, mini­mally invasive procedure in which the portal branches of the side of the liver to be resected are embolized, leading to atrophy of the side of the liver to be resected and compensatory hyper­trophy of the FLR [17− 19]. PVE should be con- sidered if pretreatment measurement of the FLR (Fig. 17.1) shows insufficient FLR volume.
Several studies have demonstrated the efficacy of PVE in terms of hepatic functional shift from the embolized liver to the FLR and reduction of surgical risk. First, dynamic functional shift from the embolized liver to the FLR after PVE was confirmed by three studies using indocyanine green excretion rate [20], technetium Tc- 99m galactosyl human serum albumin scintigraphy [21], and bile clearance [22]. These three studies indicated that PVE produced a clear functional shift from the embolized liver to the nonembo­lized FLR with a concomitant increase in FLR volume. In addition, another study showed that when patients achieved sufficient growth of the FLR to meet the minimum criteria for FLR vol­ume, operative risk was significantly reduced compared to the risk in patients who did not meet the minimum criteria for FLR volume after PVE [5]. To maximize regeneration of the FLR after PVE, optimal selection of embolic materi­als [23] and concurrent embolization of segment
and without segment IV embolization revealed a significantly greater increase in volume in seg­ments II + III with segment IV embolization (me­dian increase, 26 vs. 54 %; p = 0.021) (Fig. 17.4).
Post-PVE sFLR is a sensitive predictor of PHI. In addition, Ribero et al. reported that de­gree of hypertrophy in the sFLR after PVE is significantly associated with surgical outcomes [26]. Degree of hypertrophy greater than 5 % after PVE along with sFLR greater than 20 % predicted good postoperative outcomes with high specificity and sensitivity in patients with normal liver function. Our group has recently found that kinetic growth rate, defined as the degree of hy­pertrophy at initial volume assessment divided by the number of weeks elapsed between PVE and initial volume assessment, further predicted the risk of PHI. Kinetic growth rate greater than
2.0 % per week is strongly associated with a low risk of postoperative morbidity and mortality ir­respective of the sFLR (Fig. 17.5) [27].
Recently, a European group reported safety and efficacy data for a short-interval, two-stage liver surgery technique consisting of an initial open right portal vein ligation with in situ split­ting of the liver parenchyma followed by re­exploration for right trisectionectomy, termed “associating liver partition and portal vein liga­tion for staged hepatectomy” or “ALPPS” [28].
17517 Postoperative Hepatic Insufficiency
Fig. 17.5 Examples of the clinical utility of kinetic growth rate (KGR). All patients had standardized future
liver remnant ( sFLR) ≥ 30 % and degree of hypertrophy (DH) ≥ 7.5 % (suggested eligibility criteria for resection);
however, KGR was a more accurate predictor of outcome. A/B: Findings in a 60-year-old man. a On the basis of the initial computed tomography (CT) scan, sFLR was esti­mated at 9 %. b Final CT 35 days after right portal vein embolization (PVE) extended to segment IV indicated an sFLR of 33 %, DH of 24 %, and KGR of 4.8 % per week. The patient had an uneventful postoperative course. C/D: Findings in a 37-year-old woman. c On the basis of the
The combination of portal vein ligation and in situ splitting of the liver to prevent crossportal circulation between the lobes of the liver was believed to lead to profound hypertrophy of the FLR. However, preliminary data suggested that this new procedure was associated with a high
initial CT scan, sFLR was estimated at 15 %. d Final CT 35 days after right PVE extended to segment IV indicated an sFLR of 30 %, DH of 15 %, and KGR of 3.0 % per week. The patient had an uneventful postoperative course. E/F: Findings in a 43-year-old man. e On the basis of the initial CT scan, sFLR was estimated at 23 %. f Final CT 70 days after right PVE extended to segment IV (required additional waiting time to attain adequate remnant vol­ume) indicated an sFLR of 31 %, DH of 8 %, and KGR of 0.3 % per week (determined after the first CT 28 days after PVE). The patient died of postoperative liver failure. (Source: Reprinted with permission [27] ©Elsevier 2013)
incidence of major morbidity (40 %) and in­patient mortality (12 %). The true efficacy of ALPPS in the prevention of PHI remains contro­versial, and this procedure should be considered investigational at this time.
176 J. Shindoh and J.-N. Vauthey
Limiting the Duration of Preoperative Chemotherapy
Longer duration of chemotherapy has been cor­related with higher risk of liver damage, as men­tioned previously [6]. We previously showed that prolonged chemotherapy did not improve the response rate but did increase the risk of PHI among patients with colorectal liver metastases [8]. In a recent study investigating the relation­ship between duration of chemotherapy and the incidence of PHI according to FLR volume, we have shown that short-duration modern chemo­therapy (up to 3 without biologic agents does not increase the risk of PHI even
%), whereas when
20−30
tory of prolonged chemotherapy prior to surgery, sFLR should be at least 30 duration of preoperative chemotherapy should be minimized among patients with potentially re­sectable colorectal liver metastases.
months or six cycles) with or
in patients with marginal sFLR (i.e.,
the patient has a his-
% [29]. Therefore,
the
Treatment of PHI
Because clinical manifestations and severity of PHI or liver failure vary considerably from pa­tient to patient, treatment for PHI or liver fail­ure should be individualized according to the patient’s degree of functional disturbance with respect to circulation, renal function, pulmonary function, coagulation, and mental status influ­enced by hyperammonemia. Plasma exchange with or without continuous hemodiafiltration is the only effective therapy for patients suffering from severe liver failure, though whether this therapy improves survival has not been estab­lished [30]. For selected patients, rescue liver transplantation is another option. However, co­morbid conditions and underlying malignant dis­ease (even if it is resected) frequently preclude rescue liver transplantation. In addition, given the chronic shortage of liver donors, it is not ethi­cal to perform extensive hepatectomy in a patient with a high risk of PHI or liver failure and assume that rescue liver transplantation will be an option if serious complications occur. Preoperative risk
assessment and prevention of PHI are paramount in the current extensive surgical approach to hep­atobiliary malignancies.
Conclusion
The risk of postoperative mortality due to liver failure is inversely associated with the qual­ity of the underlying liver parenchyma and the volume of the FLR. The risk of PHI, which is a strong predictor of liver-related death, should be assessed by routine systematic volumetry in patients for whom major hepatectomy is being considered. If pretreatment measurement of the FLR shows insufficient FLR volume, adequate preoperative management including PVE should be added to avoid preventable morbidity or mor­tality after extensive hepatobiliary surgery.
Key Points
1. Postoperative serum peak bilirubin level of
greater than 7.0 mg/dL is a simple and reliable
definition of PHI, predicting morbidity and
death from liver failure with high sensitivity
and specificity.
2. FLR volume is a strong predictor of PHI and
death from liver failure. The minimum FLR
volume required should be determined ac-
cording to the quality of the underlying liver
parenchyma.
3. PVE is a safe and minimally invasive proce-
dure that results in hypertrophy of the FLR
and decreases the risk of PHI. PVE should be
considered for patients with insufficient FLR
volume.
4. Prolonged preoperative chemotherapy
( > 3 months) is associated with increased risk
of PHI. The possibility of liver damage should
be carefully considered in patients with a
history of prolonged chemotherapy prior to
surgery. Biopsy of the nontumorous liver pa-
renchyma should be considered in selected
patients.
5. Because of the limited availability of effec-
tive treatment for severe liver dysfunction,
17717 Postoperative Hepatic Insufficiency
prevention of PHI using systematic volumetry and adequate preoperative management is paramount in the surgical approach to hepato­biliary malignancies.
References
1. Rahbari NN, Weitz J, Hohenberger W, et al. Defini­tion and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery. 2010;147:339–51.
2. Balzan S, Belghiti J, Far criteria” tor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824–8.
3. Mullen JT, Ribero D, Reddy SK, et al. Hepatic insuf ficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007;204:854–62.
4. Vauthey JN, Abdalla face area in Western adults. Liver Transpl. 2002;8:233–40.
5. Kishi Y, and evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;250:540–8.
6. Shindoh J, Tzeng CW future liver remnan sive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. 2013;20:2493–500.
7. Kubota K, Makuuchi M, Kusaka K, et al. Measure­ment of liver volume and hepatic as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26:1176–81.
8. Kishi Y, Zorzi D, Contreras CM, et al. Extended preoperative chemotherapy does not improve patho logic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2010;17:2870–6.
9. Rubbia-Brandt L, Audard hepatic sinusoidal platin-based chemotherapy in patients with meta­static colorectal cancer. Ann Oncol. 2004;15:460–6.
Vauthey JN, Pawlik
10. apy regimen predic in 90-day mortality after surgery for hepatic colorec­tal metastases. J Clin Oncol. 2006;24:2065–72.
Abdalla EK, Denys A, Chevalier
11.
Vauthey JN. Total and segmental liver volume variations: implications for liver surgery. Surgery. 2004;135:404–10.
Maema A, Imamura H,
12. volume regeneration of split livers with partial venous disruption: a latent transplantation. Transplantation. 2002;73:765–9.
on postoperative day 5: an accurate predic-
and body weight predict total liver volume
Abdalla EK, Chun YS, et
one consecutive extended right hepatectomies:
ges O, et
EK, Doherty DA, et
, Aloia TA, et
t in patients treated with exten-
V, Sartoretti P, et
obstruction associated with oxali-
TM, Ribero D, et
ts steatohepatitis and an increase
Takayama T, et
al. The “50–50
al. Body sur-
al. Three hundred
al. Optimal
functional reserve
al. Severe
al. Chemother-
P, Nemr RA,
al. Impaired
problem in partial liver
Shindoh J, Satou S, Aoki
13. in asymmetric anatomical model in liver surgery. Hepatogastroen­terology. 2012;59:519–25.
Kawaguchi Y, Ishizawa
14. uptake function in veno-occlusive regions evaluated by real-time green. J Hepatol. 2013;58:247–53.
Mise Y, Hasegawa K, Satou S, et al. V
15. reconstruction based on virtual liver resection to avoid congestion in the liver remnant. Br J Surg. 2011;98:1742–51.
16. Mise Y, Tani K, Aoki T, et al. Virtual liver resection: computer-assisted operation planning using a three­dimensional liver representation. J Hepatobiliary Pancreat Sci. 2013;20:157–64.
Abulkhir A, Limongelli P
17. tive portal vein embolization tion: a meta-analysis. Ann Surg. 2008;247:49–57.
Giraudo G, Greget M, Oussoultzoglou
18.
­Bachellier P, Jaeck D. Preoperative contralateral por-
tal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institu­tion experience. Surgery. 2008;143:476–82.
Mueller L, Hillert C, Moller L, Krupski-Berdien G,
19. Rogiers X, Broering DC. Major hepatectomy for colorectal sion an oncological risk factor? Ann Surg Oncol. 2008;15:1908–17.
Uesaka K, Nimura Y, Nagino M. Changes in hepatic
20. lobar
function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg. 1996;223:77–83.
Hirai I, Kimura W
21. uation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery. 2003;133:495–506.
Ijichi M, Makuuchi M, Imamura H, Takayama
22. Portal embolization relieves persistent jaundice after
­complete biliary drainage. Surgery. 2001;130:116–8.
Madoff DC, Abdalla
23. ipsilateral segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol. 2005;16:215–25.
Kishi Y, Madof
24. tion of segment 4 portal veins before extended right hepatectomy justified? Surgery. 2008;144:744–51.
Nagino M, Kamiya J, Kanai M, et al. Right triseg-
25. ment portal vein embolization cinoma: technique and clinical utility. Surgery. 2000;127:155–60.
Ribero D, Abdalla
26. Loyer EM, Vauthey JN. Portal vein emboliza­tion before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94:1386–94.
morphology: significance of Hjortsjo’s
fluorescent imaging using indocyanine
metastases: is preoperative portal occlu-
, Fuse A, Suto K, Urayama M. Eval-
EK, Gupta S, et
right portal vein embolization extended to
f DC, Abdalla EK, et
EK, Madoff DC, Donadon M,
al. Hidden symmetry
T, et
T, Miyata Y, et
, Healey AJ, et
for major liver resec-
al. Preopera-
al. Transhepatic
al. Is emboliza-
for biliary tract car-
al. Portal
E, Rosso E,
enous
T.
178 J. Shindoh and J.-N. Vauthey
27. Shindoh J, Truty MJ, Aloia TA, et al. Kinetic growth rate after portal vein embolization predicts posthepa­tectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013;216:201–9.
28.
Schnitzbauer AA, Lang SA, Goessmann H, et al.
Right portal vein ligation combined with in situ split ting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–14.
29.
Shindoh J, Andreou A,
invasion does not predict long-term tocellular carcinoma up to 2 staging system for solitary tumors. Ann Surg Oncol. 2013;20:1223–9.
Aloia TA, et
cm: reappraisal
al. Microvascular
survival in hepa-
of the
30.
Onodera K, Sakata H, Yonekawa M, Kawamura
Artificial liver support at present and in the future. J Artif Organs. 2006;9:17–28.
31.
van den Broek MA, Olde Damink SW, Dejong CH,
al. Liver failure after partial hepatic resection: defi-
et nition, pathophysiology, risk factors and treatment. Liver Int. 2008;28:767–80.
-
32.
Azoulay D, Castaing D, Smail
V, Laurent A, Lemoine A, Bismuth H. Resection of nonresectable liver metastases from colorectal can­cer after percutaneous portal vein embolization. Ann Surg. 2000;231(4):480–6.
A, Adam R, Cailliez
A.
Biliary Leaks and Thoracobiliary Fistula
Kengo Asai and David M. Nagorney
18
Introduction
The potential for a biliary leak and fistula exists whenever procedures are performed on the bili­ary tract. These procedures include a wide range of operations that may be performed by the gen­eral or hepatopancreaticobiliary surgeon. Lapa­roscopic cholecystectomies to more complex procedures such as liver and bile duct resections and pancreaticoduodenectomy all have an associ­ated risk of biliary leakage. A persistent biliary leak can be a significant source of postoperative morbidity, has been associated with increased mortality, and in the setting of malignancy may affect survival. Thus, an understanding of the risk factors, diagnosis, prevention, and management of biliary leaks is relevant for any surgeon under­taking procedures of the biliary tract.
D. M. Nagorney () · K. Asai Department of Surgery, Division of Subspecialty General Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA e-mail: nagorney.david@mayo.edu
K. Asai e-mail: asai.kengo@mayo.edu
Definitions
Biliary Leak and Grading System
Multiple definitions of a postoperative biliary leak exist in the literature. Most definitions of biliary leak require a measured volume of bil­ious output, typically ranging from 20 to 50 mL/ day, or a concentration of bilirubin, ranging from 5 to 20 mg/dL, in the drain effluent [1]. Drain­age from a biloma (contained) or bile peritoni­tis (uncontained) is also consistent with a biliary leak. Because of the lack of a uniform definition for biliary leak in the literature, the Internation­al Study Group of Liver Surgery (ISGLS) pro­posed a formal definition and grading system in 2011 [1]. The ISGLS defines a biliary leak as a bilirubin concentration in the drain fluid at least three-times the serum bilirubin concentration on or after postoperative day 3. This classification scheme is applicable to radiologic or operative procedures for bilomas or bile peritonitis as well. Drain volume was not included because the pres­ence of ascites and lymphatic leaks confounds ac­curate measurement. However, most authors sug­gest a volume of output greater than 100–200 cc/ day as sufficient to warrant intervention [2].
The ISGLS also proposed a grading system to stratify the severity of the biliary leak. Grade A biliary leaks do not affect clinical management (Table 18.1). Grade B biliary leaks require active therapeutic intervention either radiographically or endoscopically, and Grade C biliary leaks re­quire operative intervention. Biliary leaks may
T. M. Pawlik et al. (eds.), Gastrointestinal Surgery, DOI 10.1007/978-1-4939-2223-9_18, © Springer Science+Business Media New York 2015
179
180 K. Asai and D. M. Nagorney
Table 18.1  ISGLS biliary leak grading system
Grade Change in clinical management
A No or minimal B Radiographic or endoscopic intervention or Grade A for
C Operative intervention
Biliary leak defined as bilirubin concentration 3 × serum bilirubin on or after postoperative day 3 or if procedure per­formed to manage leak ISGLS International Study Group of Livery Sur
gery
1 week
>
resolve or persist. Uncontained or persistent bili­ary leaks that require additional intervention to control are labeled Grade B or C. A precise defi­nition for persistent bile leak has not been estab­lished. However, the ISGLS classified a biliary leak that persists for > 1 week as Grade B. Given its relatively recent publication, the proposed definitions and grading system of a biliary leak have not been validated widely.
Controlled and Uncontrolled Biliary Leaks
A controlled biliary leak occurs when there is no communication with an intraperitoneal col­lection. In contrast, an uncontrolled biliary leak communicates with an intraperitoneal collection or flows freely throughout the peritoneal cavity. An uncontrolled biliary leak generally requires further drainage or manipulation of extant drains to establish control and prevent secondary infec­tion.
Source
The source of the biliary leak can either arise from an incomplete division or disrupted side branch of the involved duct that is contiguous or communicates with that duct distally or a com­plete division of the involved duct that becomes discontiguous and does not communicate with that duct distally. The former sources are likely to resolve without operative intervention while the latter typically require such intervention. Dis­contiguous ductal injuries from an entire liver segment or more that lack communication with the central biliary tree are also termed excluded
or orphan leaks [3]. These biliary leaks generally persist because the parenchyma harboring that duct maintains its vascularity. A classic example of this biliary leak would be a divided right seg­mental or sectional biliary duct after laparoscopic cholecystectomy. Regardless, the source of the biliary leak has implications on its diagnosis and management.
Risk Factors and Prevention
Risk factors and prevention of biliary leaks from the extrahepatic biliary system during laparo­scopic cholecystectomy and bilioenteric anas­tomoses will be followed by discussion of bile leaks following hepatic resection.
Biliary leaks after laparoscopic cholecystecto­my is estimated at 0.3–0.5 % [4]. Given the large number of cholecystectomies performed annu­ally, this operation is associated most commonly with biliary leaks. The cystic duct stump, ducts of Luschka, other ducts in the gallbladder fossa, and major extrahepatic bile ducts comprise the potential sites of biliary leakage. The cystic duct stump represents the most common site of leak and reported risk factors include emergency sur­gery, incomplete or disrupted closure of the cys­tic duct, width and degree of inflammation of the cystic duct, and presence of common bile duct stones [5, 6]. The risk factors for biliary leaks related to major bile duct injury and classifica­tion of biliary injury following cholecystectomy have been reported previously and a complete discussion is beyond the scope of this chapter [7]. Commonly cited factors include operator inexperience and technical errors, inflammation, and most importantly anatomic misidentification of the extrahepatic bile duct.
18118 Biliary Leaks and Thoracobiliary Fistula
Prevention
To prevent cystic duct stump leaks, one must en­sure the cystic duct stump is appropriately identi­fied and secured. A variety of methods of secur­ing the cystic duct stump have been described. These include use of titanium clips, locking clips, harmonic scalpel, suture ligature, and endovascu­lar stapling devices. There is no evidence-based data to suggest that any one method is vastly superior. The technique used should ensure that the clip or device is securely fastened, will not be dislodged, and should span the entire cystic duct. The cystic duct wall must be vascularized and free of significant inflammation. For a wide cystic duct, additional clips, ligature, or an endo­vascular stapler may be used after confirming the anatomy. Cautery injury proximal to the site of ligation should be avoided by careful dissection and use of cautery. Gentle traction should be used to avoid avulsion of the cystic duct from the com­mon hepatic duct. Leakage from ducts of Lusch­ka or from the fossa is likely related to dissec­tion into the liver parenchyma. Efforts to stay in the correct plane and ligation of accessory ducts entering the gallbladder from the fossa should decrease peripheral biliary leaks. Preventing bili­ary leaks from major bile duct injuries requires correct identification of the anatomy. The critical view of safety in which the cystic duct and cystic artery are isolated and the cystic plate is exposed has been shown to decrease the rate of major biliary injuries [8]. The role of routine cholan­giography to prevent injury is controversial [9]. Clearly cholangiography can define anatomy and unsuspected injury intraoperatively. Selective in­traoperative cholangiography based on operative conditions and lack of anatomic clarity is utilized most frequently but such use does not address misidentification errors.
Risk Factors for Bile Leaks After Extrahepatic Bilioenteric Anastomosis
Excluding the transplant population, few stud­ies have investigated risk factors for biliary leaks after bilioenteric anastomoses. Biliary
reconstruction to the small bowel is undertaken through Roux-en-Y hepaticojejunostomy or he­patico- or choledochoduodenostomy. Typically, Roux-en-Y hepaticojejunostomy is favored be­cause anastomotic leaks actually represent a pure biliary fistula as reflux of enteric content through the fistula is rare with appropriate length of construction of the Roux limb. In contrast, bili­ary anastomoses to the duodenum are not pure biliary fistulae because gastroduodenal contents are constantly exposed to the fistula site and comprise part of the effluent. The volume and contents of the effluent from these biliary leaks likely contribute to their severity. Roux-en-Y he­paticojejunostomy is the most versatile biliary reconstruction method. It can be used in any op­eration after transection of the extrahepatic bile duct. In a review of 519 hepaticojejunostomies performed for a wide range of indications includ­ing pancreatic cancer, chronic pancreatitis, chol­angiocarcinoma, and transplantation, bile leaks occurred in 5.6 % of patients [10]. Independent risk factors for leakage were preoperative radio­chemotherapy, preoperative low cholinesterase levels, simultaneous liver resection, and reopera­tion after liver transplant. Another high-volume center reported hepaticojejunostomy leak rates of
2.2 % after pancreaticoduodenectomy [11]. The only risk factor identified was a low preoperative albumin.
Hepatico- or choledochoduodenostomy either in an end-to-side or side-to-side fashion can be used in the setting of biliary calculus, strictures, bile duct cysts, and malignancy. Concerns about choledochoduodenostomy include sump syn­drome and potential for duodenal fistula in the event of anastomotic leak. Sump syndrome can occur with side-to-side choledochoduodenosto­my with the accumulation of debris in the distal blind end of the bile duct. One recent retrospec­tive study demonstrated fewer anastomotic com­plications when the duodenum was used for bili­ary reconstruction [12] and no difference in fre­quency of biliary fistulae following end-to-side choledochoduodenostomy (8 %) when compared with Roux-en-Y jejunal reconstruction (16 %). It should be noted, however, that Roux-en-Y was used more frequently when the reconstruction
182 K. Asai and D. M. Nagorney
was above the confluence. In another retrospec­tive review from India, 270 patients underwent side-to-side choledochoduodenostomy with a biliary leak documented in 2 % of patients [13]. Sump syndrome was not observed in any of these patients, the majority of whom underwent preop­erative endoscopic retrograde cholangiography (ERC) and papillotomy. While retrospective, these studies suggest the frequency of biliary leaks may be comparable to Roux-en-Y recon­struction with low incidence of sump syndrome.
Choledochocholedochostomy is primarily used in the setting of orthotopic liver transplan­tation (OLT), but has also been described in the repair of bile duct injuries. In general, end-to-end choledochocholedochostomy has not been fa­vored for repair of iatrogenic bile duct injuries given concern for subsequent stricture formation [14]). Limited data exist to support this technique outside of transplant. One retrospective study comparing Roux-Y hepaticojejunostomy with end-to-end reconstruction in 94 patients demon­strated similar rates of biliary leaks and bilomas (10 and 7 % respectively) [15]. End–end recon­struction was used with ducts greater than 4 mm in diameter in the absence of inflammation. With a mean long-term follow-up of 62 months, no significant difference in strictures was identified.
In contrast to bile duct injuries, choledocho­choledochostomy is commonly used in ortho­topic liver transplantation. A recent systematic review of over 11,000 orthotopic liver transplants documented biliary leaks in 8 % of cases [16]. The use of T-tubes to reduce biliary complica­tions remains an area of debate. Numerous pro­spective randomized trials have been performed to address this issue with conflicting results [17]. Many centers have abandoned routine use of T­tubes given the evidence from several prospec­tive randomized trials indicating the anastomoses can be performed with similar or lower rates of strictures and biliary leaks. Indeed, in the sys­tematic review by Akamatsu et al., 82 % of over 6000 deceased donor liver transplantations with duct-to-duct anastomoses were performed with­out a T-tube. In contrast, many centers continue to use splinting stents for biliary reconstruction during live donor liver transplantation, and use of
a transcystic stent for biliary reconstruction dur­ing OLT has also been described [18].
Prevention
Specific criteria for optimal construction of bil­ioenteric anastomoses are sparse and techniques vary widely. Primary recommendations for pre­vention of biliary leaks after bilioenteric anasto­moses are (1) well-vascularized bile duct, (2) ab­sence of cholangitis and inflammation of the bile duct, (3) tension-free anastomosis, (4) well-vas­cularized duodenum or jejunum, and (5) atrau­matic suture placement. For dilated bile ducts, a single running layer of absorbable monofilament suture is effective and efficient. For nondilated ducts or for complex biliary anastomoses involv­ing multiple ducts, interrupted absorbable sutures are used. If multiple duct orifices are present, adjacent ducts can be joined with interrupted absorbable sutures to reduce the number of bil­ioenteric anastomoses. Biliary stenting to bridge the bilioenteric anastomosis has not been shown to reduce biliary leaks after biliary reconstruc­tion. Stents, however, may be indicated to bridge anastomoses after R1–2 resection to ensure bili­ary access for subsequent intraluminal therapy or dilatation.
Risk Factors for Bile Leak After Liver Resection
Risk factors for biliary leak after hepatic resec­tion have been confounded by the lack of uni­form definition of biliary leak in the literature. Several recent studies have retrospectively inves­tigated the incidence and risk factors for biliary leaks. In a review of 2628 consecutive resections, preoperative jaundice, portal vein embolization, liver resection for biliary tumors, repeat hepatec­tomy, extended hepatectomy, caudate resection, two-staged resection, en bloc diaphragm resec­tion, bile duct resection and reconstruction, lon­ger operative duration, greater estimated blood loss (EBL), larger tumors, portal lymph node dis­section, and intraoperative transfusion were risk
18318 Biliary Leaks and Thoracobiliary Fistula
factors for biliary leak on univariable analysis [19]. Of these factors, repeat hepatectomy, bile duct resection, intraoperative transfusion, en bloc diaphragm resection and extended hepatectomy were found to be independent predictors for bili­ary leak on multivariable analysis. It is unclear whether factors such as increased blood loss or intraoperative transfusion are simply surrogates for increased operative complexity or directly af­fect biliary leaks.
In another study of 505 consecutive liver re­sections without bile duct resection, biliary leaks were identified in 6.7 able analysis identified large cut surface area, and intraoperative blood loss as independent predictors for biliary leaks [20]. In 610 patients undergoing liver resection without bile duct resection, peripheral cholangio­carcinoma, left hepatectomy including segment 1, transection plane outside of the main portal scissure, and hepatectomies including the cau­date or segment four were independent predic­tors of biliary leakage. On multivariable analysis, peripheral cholangiocarcinoma and resection of segment 4 were risk factors for bile leaks. Use of fibrin glue and cirrhosis were found to decrease the incidence of leaks [21].
Collectively, these studies suggest that com­plex liver resections involving the caudate, ex­tended hepatectomy, and increased blood loss increase the risk for biliary leak and may warrant additional methods to assess for biliostasis intra­operatively.
% of patients. Multivari-
repeat hepatectomy, a
MA), water-jet dissection, stapling devices, and energy devices, e.g., Ligasure (Valleylab, Tyco Healthcare, Boulder, CO, USA), Harmonic scalpel (Ethicon Endosurgery, Cincinnati, OH, USA), TissueLink (Salient Surgical Technolo­gies, Portsmouth, NH). No parenchymal transec­tion method has been shown superior in reducing the rate of biliary leaks. One randomized control trial assessing the impact of parenchymal transec­tion technique in 120 patients who were allocated to either clamp crushing or Ligasure showed no difference in biliary leak between groups [22]. A retrospective analysis of 141 patients undergoing hepatic resection without bilioenteric anastomo­sis compared clamp crushing, stapling, and Tis­suelink with no difference in the rate of biliary leakage [23]. Among 300 patients undergoing stapler hepatectomy, the incidence of biliary leak was 8 % and was claimed to be comparable to other parenchymal transection techniques [24]. For open or laparoscopic hepatectomy, identifi­cation and stapling transection of lobar, sectional, or segmental biliary duct provide secure closure. Minor or intrasegmental biliary ducts are secured with clips or suture ligature. Transection methods should avoid trauma to the hilar ducts that can predispose to late leaks. Laparoscopic hepatic resections utilize the Harmonic scalpel and endo­vascular staplers. The former technology likely fuses small ductules; however, conflicting data exist on the incidence of biliary leaks ranging from 24 to 1 % [25, 26].
Prevention of Biliary Leaks After Hepatectomy
Apart from intraoperative blood loss and transfu­sion, most identified risk factors are not modi­fiable. Techniques used to reduce intraoperative blood loss and transfusion requirements include use of intermittent inflow occlusion, low cen­tral venous pressure, and meticulous hemostatic technique. A variety of parenchymal transection techniques have been described. These include the clamp crush, Cavitron ultrasonic surgical aspirator (CUSA-Tyco Healthcare, Mansfield,
Intraoperative Tests for Bile Leaks
A variety of methods have been used to detect biliary leaks intraoperatively. A simple method to assess for biliary leaks is to place a white surgical sponge on the cut surface to detect bile staining. Identified sites of bile leakage are oversewn with suture. However, this method is dependent upon bile flow. Evacuation of bile from the biliary ducts intraoperatively may lead to falsely nega­tive findings. Other intraoperative biliary leak tests utilize perfusion of the ducts. These meth­ods include the injection of saline, methylene blue, or indocyanine green retrograde through the